儿童非酒精性脂肪性肝病的危险因素及预防管理

姚诚子; 刘自珍; 冯巩; 贺娜; 弥曼

doi:10.3969/j.issn.1001-5256.2020.07.038

儿童非酒精性脂肪性肝病的危险因素及预防管理

DOI: 10.3969/j.issn.1001-5256.2020.07.038

1. 西安医学院
2. 西安医学院第一附属医院

基金项目:

陕西省普通高等学校优势学科建设项目(陕教位[2014]3号)；

详细信息

中图分类号: R725.7
计量
- 文章访问数: 697
- HTML全文浏览量: 28
- PDF下载量: 170
- 被引次数: 0
出版历程
- 出版日期: 2020-07-20

Risk factors for childhood nonalcoholic fatty liver disease and related prevention and management strategies

1. Xi’an Medical University, Xi’an 710021, China
2. The First Affiliated Hospital of Xi’an Medical University, Xi’an 710021, China

Research funding:

摘要

摘要:
儿童非酒精性脂肪肝(NAFLD)是儿童和青少年慢性肝病最常见的病因之一,其独特的组织病理学和临床特征,导致该类疾病不仅可以发展为肝纤维化、肝硬化、肝癌,而且相对于成人NAFLD,更易导致其他重大相关性疾病的发生,增加病死率。因此,早期识别儿童NAFLD的危险因素,对高危人群进行有效筛查,积极预防,并尽早诊治,是临床有效管理该疾病的关键所在。阐述了儿童NAFLD的危险因素、筛查方式、预防保健措施等,旨在规范该病综合管理,降低患病率,延缓进展,减轻疾病所带来的经济及公共卫生负担。
- 非酒精性脂肪性肝病 /
- 儿童 /
- 危险因素 /
- 多相筛查
Abstract:
Childhood nonalcoholic fatty liver disease( NAFLD) is one of the most common cause of chronic liver diseases in children and adolescents; its unique histopathological and clinical features may lead to its progression to liver fibrosis,liver cirrhosis,and liver cancer,and compared with adult NAFLD,it is more likely to cause other diseases and increase mortality rate. Therefore,early identification of risk factors for childhood NAFLD,effective screening of high-risk population,active prevention,and early diagnosis and treatment are key to effective clinical management of this disease. This article elaborates on the risk factors,screening methods,and preventive healthcare measures for childhood NAFLD,in order to standardize the comprehensive management of NAFLD,reduce the prevalence rate of NAFLD,delay its progression,and alleviate the economic and public health burden brought by the disease.
- non-alcoholic fatty liver disease /
- child /
- risk factors /
- multiphasic screening

HTML全文

参考文献(39)

[1]MANN JP,TANG GY,NOBILI V,et al.Evaluations of lifestyle,dietary,and pharmacologic treatments for pediatric nonalcoholic fatty liver disease:A systematic review[J].Clin Gastroenterol Hepatol,2019,17(8):1457-1476.e7．

[2]DOYCHEVA I,ISSA D,WATT KD,et al.Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in young adults in the United States[J].J Clin Gastroenterol,2018,52(4):339-346．

[3]CRESPO M,LAPPE S,FELDSTEIN AE,et al.Similarities and differences between pediatric and adult nonalcoholic fatty liver disease[J].Metabolism,2016,65(8):1161-1171．

[4]GOYAL NP,SCHWIMMER JB.The genetics of pediatric nonalcoholic fatty liver disease[J].Clin Liver Dis,2018,22(1):59-71．

[5]STENDER S,KOZLITINA J,NORDESTGAARD BG,et al.Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci[J].Nat Genet,2017,49(6):842-847．

[6]BRAUN HA,FAASSE SA,VOS MB.Advances in pediatric fatty liver disease:Pathogenesis,diagnosis,and treatment[J].Gastroenterol Clin North Am,2018,47(4):949-968．

[7]KO JS.New perspectives in pediatric nonalcoholic fatty liver disease:Epidemiology,genetics,diagnosis,and natural history[J].Pediatr Gastroenterol Hepatol Nutr,2019,22(6):501-510．

[8]SANTORO N,ZHANG CK,ZHAO H,et al.Variant in the glucokinase regulatory protein(GCKR)gene is associated with fatty liver in obese children and adolescents[J].Hepatology,2012,55(3):781-789．

[9]FANG YL,CHEN H,WANG CL,et al.Pathogenesis of non-alcoholic fatty liver disease in children and adolescence:From“two hit theory”to“multiple hit model”[J].World J Gastroenterol,2018,24(27):2974-2983．

[10]DAI D,WEN F,ZHOU S,et al.Association of MTTP gene variants with pediatric NAFLD:A candidate-gene-based analysis of single nucleotide variations in obese children[J].PLo S One,2017,12(9):e0185396．

[11]CHENG X,YAMAUCHI J,LEE S,et al.APOC3 protein is not a predisposing factor for fat-induced nonalcoholic fatty liver disease in mice[J].J Biol Chem,2017,292(9):3692-3705．

[12]ISLAM S,WON J,KHAN M,et al.Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis[J].Ann Hepatol,2019.[Online ahead of print]

[13]LIN YC,CHANG PF,CHANG MH,et al.A common variant in the peroxisome proliferator-activated receptor-γcoactivator-1αgene is associated with nonalcoholic fatty liver disease in obese children[J].Am J Clin Nutr,2013,97(2):326-331．

[14]KAWAGUCHI T,SHIMA T,MIZUNO M,et al.Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers[J].PLo S One,2018,13(1):e0185490．

[15]NOBILI V,ALISI A,VALENTI L,et al.NAFLD in children:New genes,new diagnostic modalities and new drugs[J].Nat Rev Gastroenterol Hepatol,2019,16(9):517-530．

[16]RINELLA ME.Nonalcoholic fatty liver disease:A systematic review[J].JAMA,2015,313(22):2263-2273．

[17]MENG L,LUO N,MI J.Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?[J].Biomed Environ Sci,2011,24(1):22-30．

[18]ASSUNCAO S,SORTE N,ALVES CD,et al.Nonalcoholic fatty liver disease(NAFLD)pathophysiology in obese children and adolescents:Update[J].Nutr Hosp,2017,34(3):727-730．

[19]MCGEOCH LJ,PATEL PR,MANN JP.PNPLA3:A determinant of response to low-fructose diet in nonalcoholic fatty liver disease[J].Gastroenterology,2018,154(4):1207-1208．

[20]JENSEN T,ABDELMALEK MF,SULLIVAN S,et al.Fructose and sugar:A major mediator of non-alcoholic fatty liver disease[J].JHepatol,2018,68(5):1063-1075．

[21]O'SULLIVAN TA,ODDY WH,BREMNER AP,et al.Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity[J].J Pediatr Gastroenterol Nutr,2014,58(5):624-631．

[22]LEGRY V,FRANCQUE S,HAAS JT,et al.Bile acid alterations are associated with insulin resistance,but not with NASH,in obese subjects[J].J Clin Endocrinol Metab,2017,102(10):3783-3794．

[23]HUSSAIN T,MARGOOB MA,SHOIB S,et al.Prevalence of metabolic syndrome among psychiatric inpatients:A hospital based study from kashmir[J].J Clin Diagn Res,2017,11(6):VC05-VC08．

[24]HEGARTY R,DEHERAGODA M,FITZPATRICK E,et al.Paediatric fatty liver disease(Pe FLD):All is not NAFLD-Pathophysiological insights and approach to management[J].J Hepatol,2018,68(6):1286-1299．

[25]VALENTINI D,ALISI A,DI CAMILLO C,et al.Nonalcoholic fatty liver disease in italian children with down syndrome:Prevalence and correlation with obesity-related features[J].J Pediatr,2017,189:92-97.e1．

[26]GATHERCOLE LL,HAZLEHURST JM,ARMSTRONG MJ,et al.Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with alstr9m syndrome[J].Liver Int,2016,36(11):1704-1712．

[27]SHEDLOCK K,SUSI A,GORMAN GH,et al.Autism spectrum disorders and metabolic complications of obesity[J].J Pediatr,2016,178:183-187.e1．

[28]PATEL KR,WHITE FV,DEUTSCH GH.Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus[J].J Pediatr Gastroenterol Nutr,2015,60(2):152-158．

[29]BELLATORRE A,SCHERZINGER A,STAMM E,et al.Fetal overnutrition and adolescent hepatic fat fraction:The exploring perinatal outcomes in children study[J].J Pediatr,2018,192:165-170.e1．

[30]VOS MB,ABRAMS SH,BARLOW SE,et al.NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children:Recommendations from the Expert Committee on NAFLD(ECON)and the North American Society of Pediatric Gastroenterology,Hepatology and Nutrition(NASPGHAN)[J].J Pediatr Gastroenterol Nutr,2017,64(2):319-334．

[31]DI SESSA A,CIRILLO G,GUARINO S,et al.Pediatric non-alcoholic fatty liver disease:Current perspectives on diagnosis and management[J].Pediatric Health Med Ther,2019,10:89-97．

[32]ZHOU XL,FU JF.Expert consensus on diagnosis and treatment of nonalcoholic fatty liver disease in children[J].Chin J Pract Pediatr,2018,33(7):487-492.(in Chinese)周雪莲，傅君芬．儿童非酒精性脂肪肝病诊断与治疗专家共识[J]．中国实用儿科杂志，2018,33(7):487-492．

[33]DI MARTINO M,KORYUKOVA K,BEZZI M,et al.Imaging features of non-alcoholic fatty liver disease in children and adolescents[J].Children(Basel),2017,4(8):73．

[34]DE LADINGHEN V,WONG GL,VERGNIOL J,et al.Controlled attenuation parameter(CAP)for the diagnosis of steatosis in nonalcoholic fatty liver disease[J].Gastroenterol Hepatol,2016,31(4):848-855．

[35]CHALASANI N,YOUNOSSI Z,LAVINE JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J].Gastroenterology,2012,142(7):1592-1609．

[36]WU H,WU YH,TU ZT.Clinical guidelines for general practice[M].Beijing:China Medical Science Press,2018:1.(in Chinese)吴浩，吴永浩，屠志涛．全科临床诊疗常规[M]．北京:中国医药科技出版社，2018:1．

[37] ZHONG LF.Hygiene[M].Beijing:People's Medical Publishing House,2002:234.(in Chinese)仲来福．卫生学[M]．北京:人民卫生出版社，2002:234．

[38]SHAKIR AK,SUNEJA U,SHORT KR,et al.Overview of pediatric nonalcoholic fatty liver disease:A guide for general practitioners[J].J Okla State Med Assoc,2018,111(8):806-811．

[39]National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association.Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018update[J].J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会．非酒精性脂肪性肝病防治指南(2018年更新版)[J]．临床肝胆病杂志，2018,34(5):947-957.

施引文献

资源附件(0)

访问统计